MedPath

Effects of Multimodal Treatment of Headache in a Day Clinic Service

Conditions
Headache Disorders
Interventions
Other: multimodal treatment
Registration Number
NCT05111873
Lead Sponsor
University Medicine Greifswald
Brief Summary

The observational study aims to investigate the effects of a multimodal treatment program for headache patients in a day clinic service. The setting provides one week of treatment including a combination of medical consultation, physiotherapy, psychological therapy, occupational therapy, progressive muscle relaxation and disease specific education.

Outcome measures are the disease-specific impact on daily activities, general quality of life, psychological impact and headache frequency. Moreover, the study sought to identify parameters that best predict efficacy of the intervention. Therefore, standardized questionnaires are established in three points in time, to evaluate the pre- and post-treatment status.

Detailed Description

duration of treatment: 5 days; first questionnaire (V0): minimal 4 weeks prior to the treatment appointment; second questionnaire (V1): on the first day of the treatment program; third questionnaire (V2 / Follow up): 3 month (+- 6 weeks) after finishing the treatment; data collection through patient self-report; Follow-up via mail

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • diagnosis of a headache disorder
  • written informed consent for collecting and analysing data and conducting a follow-up evaluation
Exclusion Criteria
  • premature interruption of the treatment
  • repeated treatment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
post-treatment groupmultimodal treatmentParticipants enquired after the treatment in the Neurological day clinic service
Primary Outcome Measures
NameTimeMethod
Change of Veterans RAND 12 Item Health Survey (VR-12) mental health score4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

questionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10

Secondary Outcome Measures
NameTimeMethod
Change of Pain intensity4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

average pain intensity in the last month, scale 1 to 10, higher score = worse outcome

Change of Headache Impact Test (HIT6)4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

questionnaire, patient self-report, minimum value: 36 points, maximum value: 78 points, higher score = worse outcome

Change of Depression Anxiety and Stress Scale (DASS)4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

questionnaire, patient self-report, 21 questions, 7 questions per subscale (Depression, Anxiety and Stress), minimum value: 0 points, maximum value: 21 points per subscale, higher score = worse outcome

Change of Headache frequency4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

in days per month, referring to the last month, minimum value: 0 days/month, maximum value: 30 days/month

Change of Veterans RAND 12 Item Health Survey (VR-12) physical health score4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment

questionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10

Trial Locations

Locations (1)

Department of Neurology

🇩🇪

Greifswald, Mecklenburg-Vorpommern, Germany

© Copyright 2025. All Rights Reserved by MedPath